Expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".

Bill Number: H.Res. 1318
Origin Chamber: House
Congress: 119th Congress, Session 2
Policy Area: Health
Status: Introduced
Latest Action: 2026-05-21: Referred to the House Committee on Energy and Commerce.
Last Updated: 2026-06-11T08:07:14Z

AI-Generated Summary

Purpose

This resolution expresses support for designating May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month" to raise public understanding of these rare neurodegenerative disorders.

Key Provisions

Acknowledges that progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are distinct adult-onset conditions that differ from similar diseases like Parkinson's disease, with symptoms affecting movement, balance, speech, swallowing, cognition, and vision.
Notes approximate U.S. prevalence figures of 30,000 people with PSP and 2,000 with CBD, along with common challenges such as delayed diagnosis and lack of disease-modifying treatments.
Highlights the rapid progression of these conditions, typical life expectancy of 7 to 8 years from symptom onset, and the need for more research on environmental and genetic factors.
Supports goals including increased research on diagnosis, prevention, treatments, and cures; recognition of community resilience; and commendation of caregivers, healthcare professionals, and organizations involved.

Significant Changes to Existing Law

This measure introduces no changes to existing law, as it is a non-binding resolution expressing congressional support rather than enacting new requirements or amendments.

Potential Impacts

Could increase public awareness among citizens, potentially leading to earlier recognition of symptoms and greater demand for specialized neurology care.
May encourage additional focus on research and support services by government agencies involved in health policy, such as those under the Department of Health and Human Services.
Has no direct effects on international relations.

Main Stakeholders

Individuals diagnosed with PSP or CBD and their families.
Healthcare professionals and researchers specializing in neurodegenerative diseases.
Caregivers, volunteers, and advocacy organizations.
Broader communities affected by rare disease awareness efforts.

Notable Legal, Constitutional, or Political Implications

As a House resolution, it carries no legal force and does not create enforceable obligations. It reflects a bipartisan expression of support without altering constitutional authorities or existing regulatory frameworks.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Subramanyam, Suhas [D-VA-10]

Cosponsors (27)

Rep. Scanlon, Mary Gay [D-PA-5], Rep. Bonamici, Suzanne [D-OR-1], Rep. Walkinshaw, James R. [D-VA-11], Rep. Quigley, Mike [D-IL-5], Rep. Ryan, Patrick [D-NY-18], Rep. Foushee, Valerie P. [D-NC-4], Rep. DelBene, Suzan K. [D-WA-1], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Bacon, Don [R-NE-2], Rep. Scholten, Hillary J. [D-MI-3], Rep. Lawler, Michael [R-NY-17], Rep. Garcia, Sylvia R. [D-TX-29], Rep. McClellan, Jennifer L. [D-VA-4], Rep. Stanton, Greg [D-AZ-4], Rep. Dingell, Debbie [D-MI-6], Rep. Castor, Kathy [D-FL-14], Rep. Vindman, Eugene Simon [D-VA-7], Rep. Beyer, Donald S. [D-VA-8], Rep. Cleaver, Emanuel [D-MO-5], Rep. Fletcher, Lizzie [D-TX-7], Rep. Pappas, Chris [D-NH-1], Rep. Scott, Robert C. "Bobby" [D-VA-3], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Leger Fernandez, Teresa [D-NM-3], Rep. Salinas, Andrea [D-OR-6], Rep. Tonko, Paul [D-NY-20], Rep. Ross, Deborah K. [D-NC-2]

Recent Actions

2026-05-21: Referred to the House Committee on Energy and Commerce.
2026-05-21: Submitted in House

Bill Versions

Expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month". — issued 2026-05-21 — PDF (4 pages)